Viewing Study NCT03371693

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2026-02-25 @ 1:54 AM
Study NCT ID: NCT03371693
Status: UNKNOWN
Last Update Posted: 2020-05-29
First Post: 2017-11-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer
Sponsor: Zhongnan Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Ovary Neoplasm View
None Ovarian Neoplasms View
None Epithelial Ovarian Cancer View
None Ovarian Cancer, Epithelial View
None Hyperthermic Intraperitoneal Chemotherapy(HIPEC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None hyperthermic intraperitoneal chemotherapy View
None epithelial ovarian cancer View